US › Healthcare

Perrigo Company PLC (PRGO)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$10.78+0.94%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$969.2M
Revenue YoY
-7.2%
Net profit
$-398.6M
Profit YoY
-6128.1%
EPS
$0.43
EPS estimate
$0.31
Net margin
-41.1%

EPS came in at 0.43 against a street estimate of 0.31 — a beat of 38.7%.

Key statistics

Market cap
$1.40B
Forward P/E
4.7
P/B
0.56
Book value
$18.09
EPS (TTM)
$-12.93
Dividend yield
11.25%
52-week high
$24.87
52-week low
$9.00
50-day MA
$10.56
200-day MA
$12.86
Beta
0.52

Analyst view

Analysts rate Perrigo Company PLC a buy (3 buy, 2 hold, 0 sell out of 5) with an average price target of $16.50.

Shareholding

Insiders
0.40%
Institutions
116.64%

Largest institutional holders

FundStake
BlackRock Inc12.37%
T. Rowe Price Associates, Inc.9.67%
Neuberger Berman Group LLC7.56%
Vanguard Portfolio Management, LLC5.88%
Fuller & Thaler Asset Management Inc5.54%
State Street Corp5.22%
Dimensional Fund Advisors, Inc.4.75%
Vanguard Capital Management, LLC4.49%

Recent filings & reports

DocumentDate
Board / officer change · Q2 20262026-07-06
Board / officer change · Q2 20262026-06-30
Board / officer change · Q2 20262026-06-08
Quarterly report · Q1 20262026-05-06
Results announced · Q2 20262026-05-06
Proxy statement · Q2 20262026-03-20
Annual report FY20252026-02-26
Quarterly report · Q3 20252025-11-05

Readable in the app.

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Perrigo Company PLC — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.